K. Stewart et al., UPTAKE OF ALPHA-(L)-IDURONIDASE PRODUCED BY RETROVIRALLY TRANSDUCED FIBROBLASTS INTO NEURONAL AND GLIAL-CELLS IN-VITRO, Gene therapy, 4(1), 1997, pp. 63-75
The uptake of recombinant alpha-(L)-iduronidase into glial and neurona
l cells, produced by retrovirally transduced NIH3T3 fibroblasts, was s
tudied. We demonstrate that: (1) neuronal and glial cells take up alph
a-(L)-iduronidase released into the medium by retrovirally transduced
fibroblasts expressing high levels of alpha-(L)-iduronidase; (2) both
glial and neuronal cells express the cation independent mannose-6-phos
phate receptor responsible for lysosomal enzyme uptake; and (3) uptake
of the lysosomal enzyme can be blocked by excess free mannose-6-phosp
hate, but not glucose-6-phosphate. Thus, various brain cells take up a
lpha-(L)-iduronidase, possibly through a cation independent mannose-6-
phosphate receptor mediated pathway, and this uptake is higher in acti
vely dividing or immature brain cells. Consequently, (1) neuronal meta
bolism ought to be capable of cross correction by enzyme provided by g
enetically engineered and transplanted cells provided by bone marrow t
ransplantation (BMT); (2) that BMT could have a more beneficial effect
on neurological function if performed as early as possible; and (3) g
iven that the uptake mechanism of glial cells has a higher capacity, i
t might be easier to target diseases like the leukodystrophies in whic
h lysosomal enzymes are needed in glial cells, compared to diseases wh
ere lysosomal enzymes ought to be delivered into neurons.